Indications and uses
For mydriasis and cycloplegia for diagnostic procedures.
For mydriasis and cycloplegia for diagnostic procedures.
For refraction, instill one or two drops of 1% solution in the eye(s), repeated in five minutes. If patient is not seen within 20 to 30 minutes, an additional drop may be instilled to prolong mydriatic effect. For examination of fundus, instill one or two drops of 0.5% solution 15 or 20 minutes prior to examination. Individuals with heavily pigmented irides may require higher strength or more doses. Mydriasis will...
MYDRIACYL™ (tropicamide ophthalmic solution, USP) is an anticholinergic prepared as a sterile topical ophthalmic solution in two strengths. The active ingredient is represented by the chemical structure:

Each mL of MYDRIACYL™ (tropicamide ophthalmic solution, USP) contains: Active: tropicamide 1%.
Preservative: benzalkonium chloride 0.01%. Inactives: sodium chloride, edetate disodium, hydrochloric acid and/or sodium hydroxide (to adjust pH), purified water. pH range 4.0 - 5.8.
This anticholinergic preparation blocks the responses of the sphincter muscle of the iris and the ciliary muscle to cholinergic stimulation, dilating the pupil (mydriasis). The stronger preparation (1%) also paralyzes accommodation. This preparation acts in 15-30 minutes, and the duration of activity is approximately 3-8 hours. Complete recovery from mydriasis in some individuals may require 24 hours. The weaker strength may be useful in producing mydriasis with only slight cycloplegia. Heavily pigmented irides may require more doses than lightly pigmented irides.
For mydriasis and cycloplegia for diagnostic procedures.
Contraindicated in persons showing hypersensitivity to any component of this preparation.
FOR TOPICAL OPHTHALMIC USE ONLY. NOT FOR INJECTION.
This preparation may cause CNS disturbances which may be dangerous in pediatric patients. The possibility of psychotic reactions and behavioral disturbances due to hypersensitivity to anticholinergic drugs should be considered.
Mydriatics may produce a transient elevation of intraocular pressure.
Remove contact lenses before using.
The lacrimal sac should be compressed by digital pressure for two to three minutes after instillation to reduce excessive systemic absorption.
Do not touch dropper tip to any surface, as this may contaminate the solution. Patient should be advised not to drive or engage in potentially hazardous activities while pupils are dilated. Patient may experience sensitivity to light and should protect eyes in bright illumination during dilation. Parents should be warned not to get this preparation in their child's mouth and to wash their own hands and the child's hands following administration.
Tropicamide may interfere with the antihypertensive action of carbachol, pilocarpine, or ophthalmic cholinesterase inhibitors.
There have been no long-term studies done using tropicamide in animals to evaluate carcinogenic potential.
Animal reproduction studies have not been conducted with tropicamide. It is also not known whether tropicamide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Tropicamide should be given to a pregnant woman only if clearly needed.
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when tropicamide is administered to a nursing woman.
Tropicamide may rarely cause CNS disturbances which may be dangerous in pediatric patients. Psychotic reactions, behavioral disturbances, and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs (See WARNINGS). Keep this and all medications out of the reach of children.
No overall differences in safety or effectiveness have been observed between elderly and younger patients.
Ocular: Transient stinging, blurred vision, photophobia and superficial punctuate keratitis have been reported with the use of tropicamide. Increased intraocular pressure has been reported following the use of mydriatics.
Non-Ocular: Dryness of the mouth, tachycardia, headache, allergic reactions, nausea, vomiting, pallor, central nervous system disturbances and muscle rigidity have been reported with the use of tropicamide. Psychotic reactions, behavioral disturbances, and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs.
For refraction, instill one or two drops of 1% solution in the eye(s), repeated in five minutes. If patient is not seen within 20 to 30 minutes, an additional drop may be instilled to prolong mydriatic effect. For examination of fundus, instill one or two drops of 0.5% solution 15 or 20 minutes prior to examination. Individuals with heavily pigmented irides may require higher strength or more doses. Mydriasis will reverse spontaneously with time, typically in 4 to 8 hours. However, in some cases, complete recovery may take up to 24 hours.
3 mL and 15 mL in plastic DROP-TAINER® dispensers.
1% 3 mL: NDC 0065-0355-03
15 mL: NDC 0998-0355-15
STORAGE: Store at 8° to 27°C (46° to 80°F). Do not refrigerate or store at high temperatures. Keep container tightly closed.
© 2021 Alcon Inc.
Distributed by:
ALCON LABORATORIES, INC.
Fort Worth, Texas 76134
T2018-39
Revised: November 2021
W300051445-1121 Alcon
NDC 0998-0355-15
Alcon®
Mydriacyl® 1%
(tropicamide ophthalmic solution, USP)
15 mL
Sterile
Rx Only
A Sterile Anticholinergic Agent.
USUAL DOSAGE: One or two drops topically in the eye(s). Read enclosed insert.
PRECAUTION: Do not touch dropper tip to any surface, as this may contaminate the solution.
INGREDIENTS: Each mL Contains:
Active: tropicamide 1%.
Preservative: benzalkonium chloride 0.01%.
Inactives: sodium chloride, edetate disodium, hydrochloric acid and/or sodium hydroxide (to adjust pH), purified water. pH range 4.0-5.8.
©2002, 2010 Alcon, Inc.
Alcon®
ALCON LABORATORIES, INC.
Fort Worth, Texas. 76134 USA
Product of Japan
9016373 US
STORAGE: Store at 8º-27ºC (46º-80ºF). Do not refrigerate or store at high temperatures. Keep container tightly closed.
FOR TOPICAL OPHTHALMIC USE ONLY.
SN:
LOT:
EXP.:
GTIN: 00309980355156

NDC 0998-0355-15
Alcon®
Mydriacyl® 1%
(tropicamide ophthalmic solution, USP)
Sterile 15 mL
Rx Only
FOR TOPICAL OPHTHALMIC USE ONLY
A Sterile Anticholinergic Agent.
INGREDIENTS: Each mL Contains:
Active: tropicamide 1%. Preservative: benzalkonium
chloride 0.01%. Inactives: sodium chloride, edetate
disodium, hydrochloric acid and/or sodium hydroxide
(to adjust pH), purified water. pH range 4.0-5.8.
USUAL DOSAGE: One or two drops topically
in the eye(s). Read enclosed insert.
PRECAUTION: Do not touch dropper tip to any surface,
as this may contaminate the solution.
STORAGE: Store at 8º-27ºC (46º-80ºF).
Do not refrigerate or store at high temperatures.
Keep container tightly closed.
ALCON LABORATORIES, INC.
Fort Worth, Texas. 76134 USA Printed in USA
©2002, 2004 Alcon Laboratories, Inc.
H15341 US
LOT: EXP.:

| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 208660 | Mydriacyl 1 % Ophthalmic Solution | PSN | 9 |
| 314238 | tropicamide 1 % Ophthalmic Solution | PSN | 9 |
| 208660 | tropicamide 10 MG/ML Ophthalmic Solution [Mydriacyl] | SBD | 9 |
| 314238 | tropicamide 10 MG/ML Ophthalmic Solution | SCD | 9 |
| 208660 | Mydriacyl 1 % Ophthalmic Solution | SY | 9 |
| 208660 | Mydriacyl 10 MG/ML Ophthalmic Solution | SY | 9 |
| 314238 | tropicamide 1 % Ophthalmic Solution | SY | 9 |
| Class | Version | Type | Effective |
|---|---|---|---|
| TROPICAMIDE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0998-0355-15 | Mydriacyl | 15 mL in 1 BOTTLE | SOLUTION/ DROPS | 15 | 9 | |
| 0998-0355-15 | Mydriacyl | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | 9 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0998-0355-15 | ML - Milliliter | 0998-0355 | 8165cf5c-6b49-43ff-8d41-63bcdccf95f0 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TROPICAMIDE | ACTIVE INGREDIENT | N0A3Z5XTC6 | 1 | |
| TROPICAMIDE | ACTIVE MOIETY | N0A3Z5XTC6 | 1 | |
| BENZALKONIUM CHLORIDE | INACTIVE INGREDIENT | F5UM2KM3W7 | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0998-0355 | 0998-0355-15 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TROPICAMIDE | N0A3Z5XTC6 | ACTIB |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| WATER | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION/ DROPS / OPHTHALMIC | 0.13 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION/ DROPS / OPHTHALMIC | 0.13 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION/ DROPS / OPHTHALMIC | 1 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION/ DROPS / OPHTHALMIC | 1 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A084306-001 | MYDRIACYL | TROPICAMIDE | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 |
| Application-product | TE code |
|---|---|
| A084306-001 | AT |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A084306-001 | MYDRIACYL | 1% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS, Approved before 1982 | f41ea6bd6efb… |
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A084306-001 | AT | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A084306-001 | AT | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A084306-001 | AT | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A084306-001 | AT | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A084306-001 | AT | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A084306-001 | AT | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A084306-001 | AT | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A084306-001 | AT | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A084306-001 | AT | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A084306-001 | AT | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A084306-001 | AT | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A084306-001 | AT | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A084306-001 | AT | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A084306-001 | AT | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A084306-001 | AT | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A084306-001 | AT | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A084306-001 | AT | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A084306-001 | AT | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A084306-001 | AT | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A084306-001 | AT | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A084306-001 | AT | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A084306-001 | AT | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A084306-001 | AT | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A084306-001 | AT | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A084306-001 | AT | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A084306-001 | AT | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A084306-001 | AT | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A084306-001 | AT | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A084306-001 | AT | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A084306-001 | AT | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A084306-001 | AT | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A084306-001 | AT | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A084306-001 | AT | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A084306-001 | AT | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A084306-001 | AT | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A084306-001 | AT | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A084306-001 | AT | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A084306-001 | AT | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A084306-001 | AT | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A084306-001 | AT | 1 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mydriacyl | TROPICAMIDE | Alcon Laboratories, Inc. | 0d4f4a2e-eb00-4c65-b3fa-baf5738d468d | 2023-02-15 | Warnings, Adverse reactions | 0998-0355-15 0998-0355 00998035515 86af6085-d52b-4516-8234-64ae8baa98b4 0d4f4a2e-eb00-4c65-b3fa-baf5738d468d |
Adverse event summaries are temporarily unavailable. Other product information remains available.